← All stocks

Barinthus Biotherapeutics plc.

BRNS Net buying

CIK 0001828185 #4953 in the set updated 21 Sep 2026

Bought (120 mo)

$12.60M

out of their own pocket, the only kind of buying there is

Sold (120 mo)

$461.55K

$0.00 on a plan · $309.22K straight out of an exercise

Sold at will

$152.33K

6 of 15 sales

Net

+$12.14M

+$12.45M against sales at will

By person

13 insiders · 29 transactions

7.1×

William Enright holds 7.1 times base salary in stock. $4.70M of shares against $653.43K in salary for 2025.

Salary from the company's own proxy. The shares are what William Enright last reported holding, valued at $2.44, the price Ordinary Shares was last bought or sold at on the open market here, on 26 Jun 2023.

Insider

Role

Bought

Sold

Net

Holding

Worth

Change

Oxford Science Enterprises plc entity

10% owner

$10.20M (1)

—

+$10.20M

16,995,540

$41.47M

+107.3%

M&G INVESTMENT MANAGEMENT LTD entity

10% owner

$1.80M (1)

—

+$1.80M

6,285,946

$15.34M

+206.3%

Wright Robin

Director

$374.31K (3)

—

+$374.31K

$0.00

−100.0%

Ellis Christopher

Chief Operating Officer

$1.28K (1)

$309.18K (8) scheduled

−$307.90K

$183.00

—

Scheeren Joseph

Director

$126.30K (3)

—

+$126.30K

$0.00

—

Griffiths Graham

Chief Business Officer

$1.70K (1)

$116.08K (6)

−$114.38K

104,209

$254.27K

−10.0%

Phillips Anne M.

Director

$51.00K (1)

—

+$51.00K

$0.00

—

Enright William

Chief Executive Officer

—

$36.30K (1)

−$36.30K

1,927,683

$4.70M

−29.4%

DAWES KAREN A

Director

$28.90K (1)

—

+$28.90K

$0.00

—

Hammacher Alex

Director

$21.14K (2)

—

+$21.14K

$0.00

—

Morgon Pierre A.

Director

—

$0.00

−100.0%

Hooftman Leon

Chief Medical Officer

—

$0.00

—

M&G Alternatives Investment Management Ltd entity

10% owner

—

$0.00

−100.0%

No percentages here. These insiders hold more than one class of share between them, and the share count on file covers one of them rather than all. Dividing the two would compare different things.

Individual transactions

Nothing of that kind in this period.

What was left out

Form 4 filings counted 87

Amendments (4/A) skipped 2

Filings about a different issuer 0

Unreadable filings 0

Joint filings 0

Sales on a Rule 10b5-1 plan 0

Sales straight out of an exercise 9

Sales at will 6

Transactions with no price 0

Shares from compensation/vesting 18,984,391

Sales filed before the plan box existed 5

History held since 3 May 2021